Bellus Health initiates phase I study of BLU-5937 for the treatment of chronic cough July 10, 2018 No Comments
mAChR antagonists/beta2-adrenoceptor agonists patented by Beijing Showby Pharmaceutical July 9, 2018 No Comments
Galapagos reports topline results for GLPG-2737, updates triple combination plans in cystic fibrosis June 29, 2018 No Comments
Faron Pharmaceuticals presents biomarker analysis of the phase III INTEREST trial June 15, 2018 No Comments
Researchers unveil TMEM16A as potential therapeutic target for cystic fibrosis June 8, 2018 No Comments
RSS